Munich
Germany
252
2022-12-08
The entities that hold a legal rights for patent applications filed by inventor SINGH Harpreet:
Harpreet SINGH from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
Peptides and T cells for use in immunotherapeutic treatment of various cancers
#2 | 2022-11-10Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
#3 | 2022-10-20Peptides and T cells for use in immunotherapeutic treatment of various cancers
#4 | 2022-03-01Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#5 | 2022-02-10Peptides and combination of peptides for use in immunotherapy against various tumors
#6 | 2022-01-20Peptides and combination of peptides for use in immunotherapy against various tumors
#7 | 2022-01-13Peptides and combination of peptides for use in immunotherapy against various tumors
#8 | 2022-01-06Peptides and combination of peptides for use in immunotherapy against various tumors
#9 | 2021-12-30Peptides and combination of peptides for use in immunotherapy against various tumors
#10 | 2021-12-23Peptides and combination of peptides for use in immunotherapy against various tumors
#11 | 2021-12-23Peptides and combination of peptides for use in immunotherapy against various tumors
#12 | 2021-12-23Peptides and combination of peptides for use in immunotherapy against various tumors
#13 | 2021-12-23Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#14 | 2021-12-23Personalized immunotherapy against several neuronal and brain tumors
#15 | 2021-12-09Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#16 | 2021-12-02Personalized immunotherapy against several neuronal and brain tumors
#17 | 2021-11-25Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#18 | 2021-11-25Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#19 | 2021-11-25Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#20 | 2021-11-25Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#21 | 2021-11-18Peptides and combination of peptides for use in immunotherapy against various cancers
#22 | 2021-11-11Immunotherapy against several tumors including neuronal and brain tumors
#23 | 2021-11-11Peptides and combination of peptides for use in immunotherapy against various cancers
#24 | 2021-11-11Immunotherapy against several tumors including gastrointestinal and gastric cancer
#25 | 2021-11-11Immunotherapy against several tumors including gastrointestinal and gastric cancer
#26 | 2021-11-04Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#27 | 2021-11-04Peptides for use in immunotherapy against cancers
#28 | 2021-11-04Peptides for use in immunotherapy against cancers
#29 | 2021-10-28A*03 restricted peptides for use in immunotherapy against cancers and related methods
#30 | 2021-10-28A*03 restricted peptides for use in immunotherapy against cancers and related methods
#31 | 2021-10-28Immunotherapy against several tumors including gastrointestinal and gastric cancer
#32 | 2021-10-21Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
#33 | 2021-10-14Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
#34 | 2021-10-07Uterine cancer treatments
#35 | 2021-09-30Uterine cancer treatments
#36 | 2021-09-23Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#37 | 2021-09-23Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#38 | 2021-09-23Peptides and combination of peptides for use in immunotherapy against various cancers
#39 | 2021-09-23Peptides and combination of peptides for use in immunotherapy against various cancers
#40 | 2021-09-23Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#41 | 2021-09-16Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#42 | 2021-09-16Peptides and combination of peptides for use in immunotherapy against various cancers
#43 | 2021-09-16Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#44 | 2021-09-09Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
#45 | 2021-09-09Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
#46 | 2021-09-09Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
#47 | 2021-09-09Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#48 | 2021-09-09B*44 restricted peptides for use in immunotherapy against cancers and related methods
#49 | 2021-09-09Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#50 | 2021-09-09Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#51 | 2021-09-09Immunotherapy against several tumors including gastrointestinal and gastric cancer
#52 | 2021-09-02Immunotherapy against several tumors including gastrointestinal and gastric cancer
#53 | 2021-08-26Immunotherapy against several tumors including neuronal and brain tumors
#54 | 2021-08-26Immunotherapy against several tumors including gastrointestinal and gastric cancer
#55 | 2021-08-19Immunotherapy against several tumors including lung cancer
#56 | 2021-08-19Immunotherapy against several tumors including neuronal and brain tumors
#57 | 2021-08-19Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#58 | 2021-08-12Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#59 | 2021-08-05Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
#60 | 2021-08-05Immunotherapy against several tumors including neuronal and brain tumors
#61 | 2021-07-29B*44 restricted peptides for use in immunotherapy against cancers and related methods
#62 | 2021-07-29Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
#63 | 2021-07-29Personalized immunotherapy against several neuronal and brain tumors
#64 | 2021-06-24Peptides and combination of peptides for use in immunotherapy against various tumors
#65 | 2021-06-24Peptides and combination of peptides for use in immunotherapy against various tumors
#66 | 2021-06-17Peptides and combination of peptides for use in immunotherapy against various tumors
#67 | 2021-06-03Immunotherapy against several tumors including gastrointestinal and gastric cancer
#68 | 2021-05-20Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#69 | 2021-05-13A*03 restricted peptides for use in immunotherapy against cancers and related methods
#70 | 2021-05-06A*03 restricted peptides for use in immunotherapy against cancers and related methods
#71 | 2021-05-06A*03 restricted peptides for use in immunotherapy against cancers and related methods
#72 | 2021-04-01B*44 restricted peptides for use in immunotherapy against cancers and related methods
#73 | 2021-04-01Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#74 | 2021-03-11Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#75 | 2021-01-28Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
#76 | 2021-01-07Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#77 | 2020-12-31Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
#78 | 2020-12-24B*44 restricted peptides for use in immunotherapy against cancers and related methods
#79 | 2020-12-24Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#80 | 2020-12-24Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers
#81 | 2020-12-24Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#82 | 2020-12-17B*44 restricted peptides for use in immunotherapy against cancers and related methods
#83 | 2020-12-10Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#84 | 2020-11-05Immunotherapy against neuronal and brain tumors
#85 | 2020-10-29B*44 restricted peptides for use in immunotherapy against cancers and related methods
#86 | 2020-10-29B*44 restricted peptides for use in immunotherapy against cancers and related methods
#87 | 2020-10-29Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#88 | 2020-10-29Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
#89 | 2020-10-29Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#90 | 2020-10-22Immunotherapy against several tumors including gastrointestinal and gastric cancer
#91 | 2020-10-15Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#92 | 2020-10-15Peptides and combination of peptides for use in immunotherapy against various tumors
#93 | 2020-10-15Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
#94 | 2020-10-15Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
#95 | 2020-10-15Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
#96 | 2020-10-15Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
#97 | 2020-10-15Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
#98 | 2020-10-15Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#99 | 2020-10-15Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#100 | 2020-10-15Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
1151971 ⎘